An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Molecular and Cellular Biology

• Publication date

  1996-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/MCB.16.9.4754PMID 8756633PMCID PMC231476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Is hypusine essential for eukaryotic cell proliferation?

  1997cited by this paper
• An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants

  1995cited by this paper
• c‐Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II.

  1994cited by this paper
• Effect of initiation factor eIF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae.

  1994cited by this paper
• Base preferences for DNA binding by the bHLH-Zip protein USF: effects of MgCl2 on specificity and comparison with binding of Myc family members.

  1994cited by this paper
• An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc

  1994cited by this paper
• Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells.

  1994cited by this paper
• Induction of mesoderm in Xenopus laevis embryos by translation initiation factor 4E.

  1994cited by this paper
• Hypusine is essential for eukaryotic cell proliferation.

  1993cited by this paper
• Opposite regulation of gene transcription and cell proliferation by c-Myc and Max.

  1993cited by this paper
• Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E

  1993cited by this paper
• The ornithine decarboxylase gene is a transcriptional target of c-Myc.

  1993cited by this paper
• Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc.

  1993cited by this paper
• Binding of myc proteins to canonical and noncanonical DNA sequences

  1993cited by this paper
• Human transcription factor USF stimulates transcription through the initiator elements of the HIV‐1 and the Ad‐ML promoters.

  1993cited by this paper
• The c‐Myc protein induces cell cycle progression and apoptosis through dimerization with Max.

  1993cited by this paper
• Direct role for Myc in transcription initiation mediated by interactions with TFII-I

  1993cited by this paper
• Oncogenic activity of the c-Myc protein requires dimerization with Max.

  1993cited by this paper
• A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice.

  1993cited by this paper
• Transcription activation by Myc and Max: flanking sequences target activation to a subset of CACGTG motifs in vivo.

  1993cited by this paper
• Translation factors as effectors of cell growth and tumorigenesis.

  1993cited by this paper
• Max and c-Myc/Max DNA-binding activities in cell extracts.

  1992cited by this paper
• Myc and Max associate in vivo.

  1992cited by this paper
• Ornithine decarboxylase activity is critical for cell transformation

  1992cited by this paper
• Myc and Max proteins possess distinct transcriptional activities

  1992cited by this paper
• Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max

  1992cited by this paper
• An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence.

  1992cited by this paper
• Ras mediates translation initiation factor 4E-induced malignant transformation.

  1992cited by this paper
• Max: functional domains and interaction with c-Myc.

  1992cited by this paper
• mRNAs containing extensive secondary structure in their 5′ non‐coding region translate efficiently in cells overexpressing initiation factor eIF‐4E.

  1992cited by this paper
• Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region.

  1991cited by this paper
• Cooperative interaction of an initiator-binding transcription initiation factor and the helix–loop–helix activator USF

  1991cited by this paper
• Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.

  1991cited by this paper
• Transgenic models of tumor development.

  1991cited by this paper
• Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells

  1991cited by this paper
• The MYC protein activates transcription of the alpha‐prothymosin gene.

  1991cited by this paper
• TFEB has DNA-binding and oligomerization properties of a unique helix-loop-helix/leucine-zipper family.

  1991cited by this paper
• Recombinant 43-kDa USF binds to DNA and activates transcription in a manner indistinguishable from that of natural 43/44-kDa USF

  1991cited by this paper
• The Xenopus B1 factor is closely related to the mammalian activator USF and is implicated in the developmental regulation of TFIIIA gene expression.

  1991cited by this paper
• Multiple mRNAs encode the murine translation initiation factor eIF-4E.

  1991cited by this paper
• Oncogenic conversion by regulatory changes in transcription factors.

  1991cited by this paper
• c-myc oncoprotein function.

  1991cited by this paper
• N‐myc disrupts protein kinase C‐mediated signal transduction in neuroblastoma.

  1991cited by this paper
• Translational control in mammalian cells.

  1991cited by this paper
• Control of c-myc regulation in normal and neoplastic cells.

  1991cited by this paper
• Are myc proteins transcription factors?

  1990cited by this paper
• An amino-terminal c-myc domain required for neoplastic transformation activates transcription

  1990cited by this paper
• TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif.

  1990cited by this paper
• Sequence-specific DNA binding by the c-Myc protein.

  1990cited by this paper
• Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap

  1990cited by this paper
• G1 events and regulation of cell proliferation.

  1989cited by this paper
• Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo.

  1989cited by this paper
• A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins.

  1989cited by this paper
• Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model.

  1988cited by this paper
• Gel retardation at low pH resolves trp repressor-DNA complexes for quantitative study.

  1988cited by this paper
• Multiple forms of the human gene-specific transcription factor USF. II. DNA binding properties and transcriptional activity of the purified HeLa USF.

  1988cited by this paper
• CDC33 encodes mRNA cap-binding protein eIF-4E of Saccharomyces cerevisiae

  1988cited by this paper
• Activation and repression of mammalian gene expression by the c-myc protein.

  1987cited by this paper
• Definition of regions in human c-myc that are involved in transformation and nuclear localization

  1987cited by this paper
• Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F.

  1987cited by this paper
• CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements

  1987cited by this paper
• A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1

  1987cited by this paper
• Amino acid sequence of the mRNA cap-binding protein from human tissues.

  1987cited by this paper
• Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region.

  1985cited by this paper
• Regulation of initiation factors during translational repression caused by serum depletion. Abundance, synthesis, and turnover rates.

  1985cited by this paper
• The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

  1985cited by this paper
• Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes.

  1984cited by this paper
• Translocations among antibody genes in human cancer.

  1983cited by this paper
• Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

  1983cited by this paper
• Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

  1983cited by this paper
• Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.

  1983cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper

• Arginine Transporters in Human Cancers: Emerging Mechanisms and Clinical Implications

  2026cites this paper
• PRSS23-eIF4E-c-Myc axis promotes gastric tumorigenesis and progression

  2025cites this paper
• RNA-binding proteins as therapeutic targets in cancer

  2025cites this paper
• Advances in understanding and targeting eIF4E activity

  2025cites this paper
• MYC: there is more to it than cancer

  2024cites this paper
• Integrating fragment-based screening with targeted protein degradation and genetic rescue to explore eIF4E function

  2024cites this paper
• The Paradox of Ribosomal Insufficiency Coupled with Increased Cancer: Shifting the Perspective from the Cancer Cell to the Microenvironment

  2024cites this paper
• Therapeutic targeting of eukaryotic initiation factor (eIF) 4E.

  2023cites this paper
• A Genome-Wide RNAi Screen Reveals Common Host–Virus Gene Signatures: Implication for Dengue Antiviral Drug Discovery

  2023cites this paper
• An RNAi screen reveals common host-virus gene signatures: implication for anti-viral drug discovery

  2022cites this paper
• Protein synthesis control in cancer: selectivity and therapeutic targeting

  2022cites this paper
• Cell autonomous and non-autonomous consequences of deviations in translation machinery on organism growth and the connecting signalling pathways

  2022cites this paper
• Revealing molecular pathways for cancer cell fitness through a genetic screen of the cancer translatome

  2021cites this paper
• Feedback‐regulated transcriptional repression of FBXO31 by c‐Myc triggers ovarian cancer tumorigenesis

  2021cites this paper
• Deep computational analysis details dysregulation of eukaryotic translation initiation complex eIF4F in human cancers.

  2021cites this paper
• Multifaceted control of mRNA translation machinery in cancer.

  2021cites this paper
• Control of the eIF4E activity: structural insights and pharmacological implications

  2021cites this paper
• The plasticity of mRNA translation during cancer progression and therapy resistance

  2021cites this paper
• Preclinical efficacy of ribavirin in SHH and group 3 medulloblastoma.

  2021cites this paper
• Deep computational analysis of human cancer and non-cancer tissues details dysregulation of eIF4F components and their interactions in human cancers

  2020cites this paper
• New Code for DNA Nucleotide Sequences

  2020cites this paper
• Transcriptional repression of p21 by EIF1AX promotes the proliferation of breast cancer cells

  2020cites this paper
• MiR-145: a potential biomarker of cancer migration and invasion.

  2019cites this paper
• AEG-1 promotes the growth of gastric cancer through the upregulation of eIF4E expression

  2019cites this paper
• Translational Regulation of Gene Expression During Oogenesis and Preimplantation Embryo Development

  2019cites this paper
• The mRNA recruiting eIF4 factors involved in protein synthesis and its regulation.

  2019cites this paper
• Cell Fate Control by Translation: mRNA Translation Initiation as a Therapeutic Target for Cancer Development and Stem Cell Fate Control

  2019cites this paper
• AEG-1 promotes the growth of gastric cancer through the upregulation of eIF4E expression

  2019cites this paper
• Revisiting β‐Catenin Signaling in T‐Cell Development and T‐Cell Acute Lymphoblastic Leukemia

  2019cites this paper
• AEG-1 promotes the growth of gastric cancer through the upregulation of eIF4E expression

  2019cites this paper
• Synthesis of novel S-linked dihydroartemisinin derivatives and evaluation of their anticancer activity.

  2019cites this paper
• Metformin blocks MYC protein synthesis in colorectal cancer via mTOR‐4EBP‐eIF4E and MNK1‐eIF4G‐eIF4E signaling

  2018cites this paper
• Effects of IKK/NF-κB signaling in MYC-driven liver tumorigenesis

  2018cites this paper
• Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia

  2018cites this paper
• Targeting BRD4 proteins suppresses the growth of NSCLC through downregulation of eIF4E expression

  2018cites this paper
• EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC.

  2018cites this paper
• A blood pact: the significance and implications of eIF4E on lymphocytic leukemia.

  2018cites this paper
• Targeting MYC in multiple myeloma

  2017cites this paper
• VIRAL REGULATION OF CAP-DEPENDENT MESSENGER RNA TRANSLATION INHIBITOR 4E-BP1 DURING MITOSIS

  2017cites this paper
• Major splice variants and multiple polyadenylation site utilization in mRNAs encoding human translation initiation factors eIF4E1 and eIF4E3 regulate the translational regulators?

  2017cites this paper
• AEG‐1 induces gastric cancer metastasis by upregulation of eIF4E expression

  2017cites this paper
• Regulation of PABP1 function by differential post-translational modification

  2016cites this paper
• MYC, Metabolic Synthetic Lethality, and Cancer.

  2016cites this paper
• New frontiers in translational control of the cancer genome

  2016cites this paper
• New frontiers in translational control of the cancer genome

  2016cites this paper
• Targeting MYC in cancer therapy: RNA processing offers new opportunities

  2016cites this paper
• Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.

  2015cites this paper
• MYC: connecting selective transcriptional control to global RNA production

  2015cites this paper
• MYC and metabolism on the path to cancer.

  2015cites this paper
• MYC, Metabolism, and Cancer.

  2015cites this paper
• Equol, an Isoflavone Metabolite, Regulates Cancer Cell Viability and Protein Synthesis Initiation via c-Myc and eIF4G*

  2015cites this paper
• The Nucleolar Protein GLTSCR2 Is an Upstream Negative Regulator of the Oncogenic Nucleophosmin-MYC Axis.

  2015cites this paper
• The PI3K-AKt-mTOR Pathway and New Tools to Prevent Acquired Hormone Resistance in Breast Cancer.

  2015cites this paper
• Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.

  2015cites this paper
• Understanding the transcriptional control of EIF4E and its dysregulation in acute myeloid leukemia: role of NF-κB

  2015cites this paper
• 38 – Molecular Basis of Prostate Cancer

  2015cites this paper
• Targeting the translation machinery in cancer

  2015cites this paper
• cycle cellulaire de l'embryon d'oursin

  2015cites this paper
• Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget

  2014cites this paper
• Investigating the cellular mechanisms that determine RNMT dependency in breast cancer cells

  2014cites this paper
• eIF4E and Its Binding Proteins

  2014cites this paper
• Melanoma and Non-Melanoma Skin Cancers

  2014cites this paper
• Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond

  2014cites this paper
• Deciphering the transcriptional regulation code in colorectal cancer genome

  2014cites this paper
• Current and Emerging Therapies Targeting Translation

  2014cites this paper
• Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer.

  2014cites this paper
• Cycle “ Myc-mediated transcription control of SAE 1 and PUMA loci in cancer and reprogramming

  2013cites this paper
• Anti-oncogenic potential of the eIF4E-binding proteins

  2013cites this paper
• eIF4F suppression in breast cancer affects maintenance and progression

  2013cites this paper
• The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia

  2013cites this paper
• Nicotine Induces the Up-regulation of the α7-Nicotinic Receptor (α7-nAChR) in Human Squamous Cell Lung Cancer Cells via the Sp1/GATA Protein Pathway

  2013cites this paper
• apoptosis in response to the combination of bortezomib and SAHA Myc regulates aggresome formation, the induction of Noxa, and

  2013cites this paper
• What a tangled web we weave: emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathway.

  2013cites this paper
• Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction.

  2013cites this paper
• TITLE: Role of Protein Synthesis Initiation Factors in Dietary Soy Isoflavone-Mediated Effects on Breast Cancer Progression. PRINCIPAL INVESTIGATOR: Columba de la Parra Simental CONTRACTING ORGANIZATION: REPORT DATE: TYPE OF REPORT:

  2013cites this paper
• eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies.

  2012influential citation
• Systemic elevation of PTEN induces a tumor-suppressive metabolic state.

  2012cites this paper
• Translational control in cancer etiology.

  2012cites this paper
• CD44/Hyaluronan signaling in advanced prostate cancer is associated with hyper- activation of eIF4E mediated translation

  2012cites this paper
• Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis.

  2012influential citation
• Eukaryotic initiation factor 4F: a vulnerability of tumor cells.

  2012cites this paper
• Award Number: W81XWH-11-1-0499 TITLE: Deciphering the Translational Determinants of Prostate Cancer Initiation and Progression PRINCIPAL INVESTIGATOR: Andrew C. Hsieh CONTRACTING ORGANIZATION: Unversity of California, San Francisco

  2012cites this paper
• Up-regulation of Translation Eukaryotic Initiation Factor 4E in Nucleophosmin 1 Haploinsufficient Cells Results in Changes in CCAAT Enhancer-binding Protein α Activity

  2012cites this paper
• Analyses structurales et fonctionnelles des interactions entre elF4E et ses partenaires

  2012cites this paper
• Emerging therapeutics targeting mRNA translation.

  2012cites this paper
• Markers for efficacy of mammalian target of rapamycin inhibitor.

  2012cites this paper
• MYC directs transcription of MCL1 and eIF4E genes to control sensitivity of gastric cancer cells toward HDAC inhibitors

  2012cites this paper
• Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells.

  2012cites this paper
• Identification of cis-Regulatory Elements in the dmyc Gene of Drosophila Melanogaster

  2011cites this paper
• The proto-oncogene c-myc in terminal B lymphocyte differentiation its role in plasma cell and memory B cell generation

  2011influential citation
• 4E‐BP1 degradation and eIF4E truncation occur spatially distinctly in the porcine uterine epithelia and are features of noninvasive implantation in the pig

  2011cites this paper
• PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis

  2011cites this paper
• Cap and cap‐binding proteins in the control of gene expression

  2011cites this paper
• Award Number: W81XWH-08-1-0747 TITLE: Approaching Resistance to Targeted Inhibition of PI3K in Breast Cancer

  2011cites this paper
• Role of the MAPK and mTORC1 Pathways mRNA Translation and Energy Metabolism in Cancer: The

  2011cites this paper
• Differential Regulation of N-Myc and c-Myc Synthesis, Degradation, and Transcriptional Activity by the Ras/Mitogen-activated Protein Kinase Pathway*

  2011cites this paper
• Mammalian target of rapamycin: a central node of complex signaling cascades.

  2011cites this paper
• Mechanisms of persistent translation arrest following global brain ischemia & reperfusion

  2011cites this paper
• mRNA translation and energy metabolism in cancer: the role of the MAPK and mTORC1 pathways.

  2011cites this paper
• Oncogenic AKTivation of translation as a therapeutic target

  2011influential citation